Aligning Science Across Parkinson's Logo Text
Submit site search
  • Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation

    By on

    The authors created mice in which endogenous a-synuclein is localized to the nucleus. The mice show motor and GI deficits and motor cortex atrophy, suggesting that chronic nuclear a-synuclein can cause toxic phenotypes independent of its aggregation.

  • RNA and protein extraction from bulk dissections

    By on

    Protocol for RNA and protein extraction from bulk dissections.

  • Create Mask for Axonal Quantification Analysis with FIJI

    By on

    This protocol describes how to create a quantified mask from an image of fluorescence-tagged axonal projections using FIJI/ImageJ software.

  • H9 ES AAVS1-NGN2 TEX264-/-

    By on

    ES cells modified using CRISPR/Cas9 lack ER-phagy receptor TEX264. They introduced a NEUROG2 construct in AAVS1 locus, derived from a female human embryonic stem cell at the blastocyst stage.

  • α-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to β-Spectrin

    By on

    α-Synuclein plays a key role in the pathogenesis of Parkinson's disease and related disorders, but critical interacting partners and molecular mechanisms mediating neurotoxicity are incompletely understood. We show that α-synuclein binds directly to β-spectrin. Using males and females in a Drosophila model of α-synuclein-related disorders, we demonstrate that β-spectrin is critical for α-synuclein neurotoxicity. Further, the ankyrin binding domain of β-spectrin is required for α-synuclein binding and neurotoxicity. A key plasma membrane target of ankyrin, Na+/K+ ATPase, is mislocalized when human α-synuclein is expressed in Drosophila Accordingly, membrane potential is depolarized in α-synuclein transgenic fly brains. We examine the same pathway in human neurons and find that Parkinson's disease patient-derived neurons with a triplication of the α-synuclein locus show disruption of the spectrin cytoskeleton, mislocalization of ankyrin and Na+/K+ ATPase, and membrane potential depolarization. Our findings define a specific molecular mechanism by which elevated levels of α-synuclein in Parkinson's disease and related α-synucleinopathies lead to neuronal dysfunction and death.SIGNIFICANCE STATEMENT The small synaptic vesicle associate protein α-synuclein plays a critical role in the pathogenesis of Parkinson's disease and related disorders, but the disease-relevant binding partners of α-synuclein and proximate pathways critical for neurotoxicity require further definition. We show that α-synuclein binds directly to β-spectrin, a key cytoskeletal protein required for localization of plasma membrane proteins and maintenance of neuronal viability. Binding of α-synuclein to β-spectrin alters the organization of the spectrin-ankyrin complex, which is critical for localization and function of integral membrane proteins, including Na+/K+ ATPase. These finding outline a previously undescribed mechanism of α-synuclein neurotoxicity and thus suggest potential new therapeutic approaches in Parkinson's disease and related disorders

  • Crystal structure of Wild-Type PPM1H phosphatase

    By on

    Crystal structure of WT PPM1H phosphatase (as reported in 10.15252/embr.202152675) deposited in the Protein Data Bank with code 7L4J.

  • LRRK1 expression and purification

    By on

    Protein purification protocol for full-length LRRK1 as done by Leschziner and Reck-Peterson Labs. Original protocol by Janice M. Reimer and Yu Xuan Lin.

  • pCAG-mcherry- WIPI2dH85E-cs- TEV -STREP

    By on

    Plasmid

  • In vitro synthesis of PE2 (nCas9-MMLV RT fusion) polyA mRNA using T7 RNA polymerase

    By on

    We describe the preparation of synthetic capped and polyadenylated messenger RNA (mRNA) encoding a Cas9 nickase-reverse transcriptase fusion protein (PE2) for use in genome editing with a method called prime editing.

  • H9 ES AAVS1-NGN2 FAM134A-/-

    By on

    Summary: H9 ES cells were modified using CRISPR/Cas9 to lack the ER-phagy receptor FAM134A. A NEUROG2 construct was introduced in the AAVS1 locus, creating iNeurons. The cells are derived from human embryonic stem cells at the blastocyst stage.

  • Microsomal membrane isolation from cell culture

    By on

    Microsomal membrane isolation from cell culture

  • Validation of Genotyping Method for L444P Mice Ear-Clips.

    By on

    || Team Schapira || Authors Revi Shahar Golan, David ChauAbstractAim: the genotyping is used to identify if mice are heterozygote (hetero) or Wild-Type (WT), and the aim of the work is to validate the digestion method, and PCR program, the PCR primers, and the interpretation of the results.   Associated with publication: doi: 10.1093/brain/awx221

  • His-ATG3-C264A

    By on

    Plasmid: ATG3 mutant overexpression in E.Coli. 6His-TEVsite-ATG3-C264A-stop.

  • Mouse Stereotaxic Surgery

    By on

    This protocol describes the steps for performing stereotaxic surgery in mice. It is applicable to intracranial injections (e.g. virus, drug) and placement of implants (e.g. optical fibers, electrode arrays) into targeted regions of mouse brains.

  • Cryosectioning Mouse Brain

    By on

    This protocol details the cryosectioning of the mouse brain.

  • An open-source head-fixation and implant-protection system for mice

    By on

    This study presents a head-fixation and implant-protection system for mice including a headbar, headhat and head fixation station to facilitate experimental procedures in vivo. All 3D-printing files are open source and readily available and editable

  • pCAG-GST-ATG14

    By on

    Plasmid for mammalian expression of GST tagged ATG14.

  • The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1

    By on

    The authors identify novel transcripts from both GBA1 and GBAP1, including protein-coding transcripts that are translated in vitro and detected in proteomic data, but that lack GCase activity.

  • GUV preparation

    By on

    Protocol for GUV preparation for membrane tube assay application.

  • CRISPR/Cas9-Based Functional Genomics in Human Induced Pluripotent Stem Cell–Derived Models: Can “the Stars Align” for Neurodegenerative Diseases?

    By on

    The article discusses the use of CRISPR/Cas9 in studying human diseases using stem cell models, highlighting its potential for advancing functional genomics research.

Load More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.